Diagnostics based on mass spectrometric detection of translated target polypeptides
AssigneeSequenom, Inc.
InventorsDaniel P. Little, Scott Higgins, Hubert Köster
Life of this patent
Estimating the term…
Loading patent…
AssigneeSequenom, Inc.
InventorsDaniel P. Little, Scott Higgins, Hubert Köster
Estimating the term…
The invention provides a means of detecting and identifying mutations in a genetic region, and a means of quantifying the number of repeat units in, for example, a trinucleotide repeat, by transcription/translation of the genetic region into a target polypeptide. The method requires neither radioisotopic nor fluorescent labeling of the target polypeptide. In particular, the invention is based on mass spectrometric determination of the mass of the encoded target polypeptide and comparison of the mass of the polypeptide with its own expected mass or with the mass of a polypeptide of known identity. Depending on the target polypeptide to be identified, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
A process for determining the genetic nature of a phenotype in a subject, comprising the steps of:
A process for obtaining sequence information or the identity of a plurality of nucleic acid molecules by determining the identities of polypeptides encoded by the nucleic acid molecules, comprising the steps of:
A process for identifying an individual having spinal cerebellar ataxia-1, comprising detecting an abnormal number of trinucleotide repeats in a nucleic acid molecule obtained from the individual, said trinucleotide repeats comprising CAG trinucleotides and at least one GAG trinucleotide.
A process for identifying the presence or absence of a mutation in a target nucleic acid sequence by determining the molecular mass of a polypeptide encoded by the nucleic acid sequence, comprising the steps of:
Dependencies are inferred from the claim text.